{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,4,5]],"date-time":"2024-04-05T00:51:13Z","timestamp":1712278273809},"reference-count":26,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,4,4]]},"DOI":"10.7759\/cureus.57587","type":"journal-article","created":{"date-parts":[[2024,4,4]],"date-time":"2024-04-04T11:17:33Z","timestamp":1712229453000},"source":"Crossref","is-referenced-by-count":0,"title":["COVID-19 and Autoimmunity in Dermatology: A Moroccan Case Series and Literature Review"],"prefix":"10.7759","author":[{"given":"Fatimazahrae","family":"Benhayoun","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fouzia","family":"Hali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fatima Zahra","family":"El Fatoiki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Soumiya","family":"Chiheb","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1111\/exd.14186","article-title":"Potential interactions of SARS-CoV-2 with human cell receptors in the skin: understanding the enigma for a lower frequency of skin lesions compared to other tissues","volume":"29","author":"Ricardo Criado P","year":"2020","unstructured":"Ricardo Criado P, Pincelli TP, Criado RF, Abdalla BM, Belda Junior W. Potential interactions of SARS-CoV-2 with human cell receptors in the skin: understanding the enigma for a lower frequency of skin lesions compared to other tissues. Exp Dermatol. 2020, 29:936-44. 10.1111\/exd.14186","journal-title":"Exp Dermatol"},{"key":"ref2","article-title":"SARS-CoV-2 infection and skin manifestations [Article in Spanish]","volume":"17","author":"Schuhler C","year":"2021","unstructured":"Schuhler C, Alberto C, Toutous-Trelluet L, al.. SARS-CoV-2 infection and skin manifestations [Article in Spanish]. Rev Med Suisse. 2021, 17:642-5.","journal-title":"Rev Med Suisse"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1111\/dth.14592","article-title":"Skin manifestations overlap in COVID-19 patients: a continuous spectrum?","volume":"34","author":"Selda-Enriquez G","year":"2021","unstructured":"Selda-Enriquez G, Fernandez-Nieto D, Burgos-Blasco P, Melian-Olivera A, Fernandez-Guarino M. Skin manifestations overlap in COVID-19 patients: a continuous spectrum?. Dermatol Ther. 2021, 34:e14592. 10.1111\/dth.14592","journal-title":"Dermatol Ther"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1111\/dth.14578","article-title":"Oral manifestations of COVID-19 disease: a review article","volume":"34","author":"Iranmanesh B","year":"2021","unstructured":"Iranmanesh B, Khalili M, Amiri R, Zartab H, Aflatoonian M. Oral manifestations of COVID-19 disease: a review article. Dermatol Ther. 2021, 34:e14578. 10.1111\/dth.14578","journal-title":"Dermatol Ther"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.19564","article-title":"Prevalence of mucocutaneous manifestations in 666 patients with COVID-19 in a field hospital in Spain: oral and palmoplantar findings","volume":"184","author":"Nuno-Gonzalez A","year":"2021","unstructured":"Nuno-Gonzalez A, Martin-Carrillo P, Magaletsky K, et al.. Prevalence of mucocutaneous manifestations in 666 patients with COVID-19 in a field hospital in Spain: oral and palmoplantar findings. Br J Dermatol. 2021, 184:184-5. 10.1111\/bjd.19564","journal-title":"Br J Dermatol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.17045","article-title":"SARS-CoV-2-induced telogen effluvium: a multicentric study","volume":"35","author":"Moreno-Arrones OM","year":"2021","unstructured":"Moreno-Arrones OM, Lobato-Berezo A, Gomez-Zubiaur A, et al.. SARS-CoV-2-induced telogen effluvium: a multicentric study. J Eur Acad Dermatol Venereol. 2021, 35:e181-3. 10.1111\/jdv.17045","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1111\/dth.15100","article-title":"Nails and COVID-19 - a comprehensive review of clinical findings and treatment","volume":"34","author":"Wollina U","year":"2021","unstructured":"Wollina U, Kanitakis J, Baran R. Nails and COVID-19 - a comprehensive review of clinical findings and treatment. Dermatol Ther. 2021, 34:e15100. 10.1111\/dth.15100","journal-title":"Dermatol Ther"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1111\/dth.14688","article-title":"Transverse orange nail lesions following SARS-CoV-2 infection","volume":"34","author":"Tammaro A","year":"2021","unstructured":"Tammaro A, Adebanjo GA, Erasmus HP, Chello C, Pezzuto A, Ramirez-Estrada S, Rello J. Transverse orange nail lesions following SARS-CoV-2 infection. Dermatol Ther. 2021, 34:e14688. 10.1111\/dth.14688","journal-title":"Dermatol Ther"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2020.102524","article-title":"Could Sars-coronavirus-2 trigger autoimmune and\/or autoinflammatory mechanisms in genetically predisposed subjects?","volume":"19","author":"Caso F","year":"2020","unstructured":"Caso F, Costa L, Ruscitti P, Navarini L, Del Puente A, Giacomelli R, Scarpa R. Could Sars-coronavirus-2 trigger autoimmune and\/or autoinflammatory mechanisms in genetically predisposed subjects?. Autoimmun Rev. 2020, 19:102524. 10.1016\/j.autrev.2020.102524","journal-title":"Autoimmun Rev"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.26513","article-title":"Systemic lupus erythematosus and varicella-like rash following COVID-19 in a previously healthy patient","volume":"93","author":"Slimani Y","year":"2021","unstructured":"Slimani Y, Abbassi R, El Fatoiki FZ, Barrou L, Chiheb S. Systemic lupus erythematosus and varicella-like rash following COVID-19 in a previously healthy patient. J Med Virol. 2021, 93:1184-7. 10.1002\/jmv.26513","journal-title":"J Med Virol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1111\/ijd.15592","article-title":"A concomitant diagnosis of COVID-19 infection and systemic lupus erythematosus complicated by a macrophage activation syndrome: A new case report","volume":"60","author":"Hali F","year":"2021","unstructured":"Hali F, Jabri H, Chiheb S, Hafiani Y, Nsiri A. A concomitant diagnosis of COVID-19 infection and systemic lupus erythematosus complicated by a macrophage activation syndrome: A new case report. Int J Dermatol. 2021, 60:1030-1. 10.1111\/ijd.15592","journal-title":"Int J Dermatol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1186\/s13256-020-02582-8","article-title":"Systemic lupus erythematosus manifestation following COVID-19: a case report","volume":"15","author":"Zamani B","year":"2021","unstructured":"Zamani B, Moeini Taba SM, Shayestehpour M. Systemic lupus erythematosus manifestation following COVID-19: a case report. J Med Case Rep. 2021, 15:29. 10.1186\/s13256-020-02582-8","journal-title":"J Med Case Rep"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.26355\/eurrev_202009_23060","article-title":"The first case of systemic lupus erythematosus (SLE) triggered by COVID-19 infection","volume":"24","author":"Bonometti R","year":"2020","unstructured":"Bonometti R, Sacchi MC, Stobbione P, et al.. The first case of systemic lupus erythematosus (SLE) triggered by COVID-19 infection. Eur Rev Med Pharmacol Sci. 2020, 24:9695-7. 10.26355\/eurrev_202009_23060","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.46889\/JCIM.2021.2106","article-title":"Morphea (localized scleroderma) in a COVID-19 patient: a case report","volume":"2","author":"Severino P","year":"2021","unstructured":"Severino P. Morphea (localized scleroderma) in a COVID-19 patient: a case report. J Clin Immunol Microbiol. 2021, 2:1-4. 10.46889\/JCIM.2021.2106","journal-title":"J Clin Immunol Microbiol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1111\/dth.14685","article-title":"Alopecia areata in a COVID-19 patient: a case report","volume":"34","author":"Capalbo A","year":"2021","unstructured":"Capalbo A, Giordano D, Gagliostro N, Balampanos CG, Persechino F, Orr\u00f9 F, Persechino S. Alopecia areata in a COVID-19 patient: a case report. Dermatol Ther. 2021, 34:e14685. 10.1111\/dth.14685","journal-title":"Dermatol Ther"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1111\/jocd.14080","article-title":"New onset of alopecia areata in a patient with SARS-CoV-2 infection: Possible pathogenetic correlations?","volume":"20","author":"Rossi A","year":"2021","unstructured":"Rossi A, Magri F, Michelini S, et al.. New onset of alopecia areata in a patient with SARS-CoV-2 infection: Possible pathogenetic correlations?. J Cosmet Dermatol. 2021, 20:2004-5. 10.1111\/jocd.14080","journal-title":"J Cosmet Dermatol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1111\/dth.14295","article-title":"Alopecia areata in a patient with SARS-Cov-2 infection","volume":"33","author":"Sgubbi P","year":"2020","unstructured":"Sgubbi P, Savoia F, Calderoni O, Longo R, Stinchi C, Tabanelli M. Alopecia areata in a patient with SARS-Cov-2 infection. Dermatol Ther. 2020, 33:e14295. 10.1111\/dth.14295","journal-title":"Dermatol Ther"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1111\/ijd.15317","article-title":"COVID-19: association with rapidly progressive forms of alopecia areata","volume":"60","author":"FIvenson D","year":"2021","unstructured":"FIvenson D. COVID-19: association with rapidly progressive forms of alopecia areata. Int J Dermatol. 2021, 60:127. 10.1111\/ijd.15317","journal-title":"Int J Dermatol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdcr.2020.10.013","article-title":"New-onset pustular psoriasis in the setting of severe acute respiratory syndrome coronavirus 2 infection causing coronavirus disease 2019","volume":"6","author":"Mathieu RJ","year":"2020","unstructured":"Mathieu RJ, Cobb CB, Telang GH, Firoz EF. New-onset pustular psoriasis in the setting of severe acute respiratory syndrome coronavirus 2 infection causing coronavirus disease 2019. JAAD Case Rep. 2020, 6:1360-2. 10.1016\/j.jdcr.2020.10.013","journal-title":"JAAD Case Rep"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1111\/dth.14595","article-title":"Generalized pustular psoriasis following COVID-19","volume":"34","author":"Shahidi Dadras M","year":"2021","unstructured":"Shahidi Dadras M, Diab R, Ahadi M, Abdollahimajd F. Generalized pustular psoriasis following COVID-19. Dermatol Ther. 2021, 34:e14595. 10.1111\/dth.14595","journal-title":"Dermatol Ther"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.728411","article-title":"Pansclerotic morphea following COVID-19: a case report and review of literature on rheumatologic and non-rheumatologic dermatologic immune-mediated disorders induced by SARS-CoV-2","volume":"8","author":"Lotfi Z","year":"2021","unstructured":"Lotfi Z, Haghighi A, Akbarzadehpasha A, Mozafarpoor S, Goodarzi A. Pansclerotic morphea following COVID-19: a case report and review of literature on rheumatologic and non-rheumatologic dermatologic immune-mediated disorders induced by SARS-CoV-2. Front Med (Lausanne). 2021, 8:728411. 10.3389\/fmed.2021.728411","journal-title":"Front Med (Lausanne)"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1111\/ced.14574","article-title":"COVID-19-induced toxic epidermal necrolysis","volume":"46","author":"Narang I","year":"2021","unstructured":"Narang I, Panthagani AP, Lewis M, Chohan B, Ferguson A, Nambi R. COVID-19-induced toxic epidermal necrolysis. Clin Exp Dermatol. 2021, 46:927-9. 10.1111\/ced.14574","journal-title":"Clin Exp Dermatol"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1111\/ajd.13444","article-title":"SDRIFE-like rash associated with COVID-19, clinicopathological correlation","volume":"62","author":"Chicharro P","year":"2021","unstructured":"Chicharro P, Rodr\u00edguez-Jim\u00e9nez P, Mu\u00f1oz-Aceituno E, De Argila D, Mu\u00f1oz-Hern\u00e1ndez P, Llamas-Velasco M. SDRIFE-like rash associated with COVID-19, clinicopathological correlation. Australas J Dermatol. 2021, 62:88-9. 10.1111\/ajd.13444","journal-title":"Australas J Dermatol"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1111\/ijd.15316","article-title":"Detection of SARS-CoV-2 in a case of DRESS by sulfasalazine: could there be a relationship with clinical importance?","volume":"60","author":"Balconi SN","year":"2021","unstructured":"Balconi SN, Lopes NT, Luzzatto L, Bonamigo RR. Detection of SARS-CoV-2 in a case of DRESS by sulfasalazine: could there be a relationship with clinical importance?. Int J Dermatol. 2021, 60:125-6. 10.1111\/ijd.15316","journal-title":"Int J Dermatol"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdermsci.2020.05.002","article-title":"Unique skin manifestations of COVID-19: Is drug eruption specific to COVID-19?","volume":"99","author":"Sakaida T","year":"2020","unstructured":"Sakaida T, Tanimoto I, Matsubara A, Nakamura M, Morita A. Unique skin manifestations of COVID-19: Is drug eruption specific to COVID-19?. J Dermatol Sci. 2020, 99:62-4. 10.1016\/j.jdermsci.2020.05.002","journal-title":"J Dermatol Sci"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.16664","article-title":"A case of cefditoren-induced acute generalized exanthematous pustulosis during COVID-19 pandemics. Severe cutaneous adverse reactions are an issue","volume":"34","author":"Torres-Navarro I","year":"2020","unstructured":"Torres-Navarro I, Abril-P\u00e9rez C, Roca-Gin\u00e9s J, S\u00e1nchez-Arr\u00e1ez J, Botella-Estrada R. A case of cefditoren-induced acute generalized exanthematous pustulosis during COVID-19 pandemics. Severe cutaneous adverse reactions are an issue. J Eur Acad Dermatol Venereol. 2020, 34:e537-9. 10.1111\/jdv.16664","journal-title":"J Eur Acad Dermatol Venereol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/157312-covid-19-and-autoimmunity-in-dermatology-a-moroccan-case-series-and-literature-review","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,4]],"date-time":"2024-04-04T11:17:39Z","timestamp":1712229459000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/157312-covid-19-and-autoimmunity-in-dermatology-a-moroccan-case-series-and-literature-review"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,4]]},"references-count":26,"URL":"https:\/\/doi.org\/10.7759\/cureus.57587","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4,4]]}}}